MPC vs RAPP · P/E 16, rev $138.86B vs $532.9M cap
Marathon Petroleum Corp (MPC) versus Rapport Therapeutics, Inc. Common Stock (RAPP) — a side-by-side from cached financials, not a winner call.
Marathon Petroleum Corp (MPC) is a oil & gas refining & marketing company listed on US.
Rapport Therapeutics, Inc. Common Stock (RAPP) is a biotechnology company listed on US.
Latest reported MPC revenue for 2024-12-31 was $138.86B. Net income was $5.07B. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
RAPP does not have a complete income-statement cache yet.
MPC currently screens at market cap $71.41B and trailing P/E 16.1. RAPP currently screens at market cap $532.9M.
Not investment advice. Open the MPC and RAPP stock pages for the full models.
Not investment advice.